Al-Marzooq F, Ghazawi A, Allam M, Collyns T
Eur J Clin Microbiol Infect Dis. 2025; .
PMID: 40019666
DOI: 10.1007/s10096-025-05082-z.
Bedenic B, Luxner J, Zarfel G, Bencic A, Sardelic S, Anusic M
Antibiotics (Basel). 2025; 14(2).
PMID: 40001398
PMC: 11851357.
DOI: 10.3390/antibiotics14020154.
Alvisi G, Curtoni A, Fonnesu R, Piazza A, Signoretto C, Piccinini G
Antibiotics (Basel). 2025; 14(2).
PMID: 40001385
PMC: 11852015.
DOI: 10.3390/antibiotics14020141.
Stasyuk A, Smith C
bioRxiv. 2025; .
PMID: 39896477
PMC: 11785024.
DOI: 10.1101/2025.01.20.633977.
Tian J, Wang C, Song P, You Z, Jia X, Li X
Can J Infect Dis Med Microbiol. 2025; 2025():6619016.
PMID: 39816186
PMC: 11729505.
DOI: 10.1155/cjid/6619016.
Carbapenemase-Producing Enterobacterales from Patients Arriving from Ukraine in Poland, March 2022-February 2023.
Biedrzycka M, Izdebski R, Hryniewicz W, Gniadkowski M, Zabicka D
Infect Dis Ther. 2025; 14(2):401-419.
PMID: 39757270
PMC: 11829885.
DOI: 10.1007/s40121-024-01097-9.
A plasmid-chromosome crosstalk in multidrug resistant enterobacteria.
Toribio-Celestino L, Calvo-Villamanan A, Herencias C, Alonso-Del Valle A, Sastre-Dominguez J, Quesada S
Nat Commun. 2024; 15(1):10859.
PMID: 39738078
PMC: 11686079.
DOI: 10.1038/s41467-024-55169-y.
Population-Based Study of Emergence and Spread of Escherichia coli Producing OXA-48-Like Carbapenemases, Israel, 2007-2023.
Temkin E, Bechor M, Lurie-Weinberger M, Keren-Paz A, Chen D, Lugassy C
Emerg Infect Dis. 2024; 31(1):66-74.
PMID: 39714269
PMC: 11682801.
DOI: 10.3201/eid3101.240722.
Comparison of Carbapenemases and Extended-Spectrum β-Lactamases and Resistance Phenotypes in Hospital- and Community-Acquired Isolates of from Croatia.
Car H, Dobric M, Pospisil M, Nad M, Luxner J, Zarfel G
Microorganisms. 2024; 12(11).
PMID: 39597613
PMC: 11596078.
DOI: 10.3390/microorganisms12112224.
The Characterisation of Carbapenem-Resistant and in a Teaching Hospital in Malaysia.
Lau M, Ponnampalavanar S, Chong C, Dwiyanto J, Lee Y, Woon J
Antibiotics (Basel). 2024; 13(11).
PMID: 39596800
PMC: 11591332.
DOI: 10.3390/antibiotics13111107.
High diversity of strain clonality and metallo-β-lactamases genes among carbapenem-resistant Enterobacterales in Taiwan.
Lee J, Kuo Y, Du S, Lee T, Liao C, Huang Y
Eur J Clin Microbiol Infect Dis. 2024; 44(2):251-262.
PMID: 39551908
DOI: 10.1007/s10096-024-04993-7.
Laboratory detection of carbapenemases among Gram-negative organisms.
Simner P, Pitout J, Dingle T
Clin Microbiol Rev. 2024; 37(4):e0005422.
PMID: 39545731
PMC: 11629623.
DOI: 10.1128/cmr.00054-22.
Molecular epidemiology of carbapenemase-producing Klebsiella pneumoniae in Gauteng South Africa.
Salvador-Oke K, Pitout J, Peirano G, Strydom K, Kingsburgh C, Ehlers M
Sci Rep. 2024; 14(1):27337.
PMID: 39521758
PMC: 11550437.
DOI: 10.1038/s41598-024-70910-9.
Multicenter evaluation of ceftazidime-avibactam use in carbapenem-resistant Klebsiella pneumoniae bloodstream infections in OXA-48 endemic regions.
Mert A, Derin O, Akalin H, Dumlu R, Gundes S, Zengin R
Sci Rep. 2024; 14(1):26337.
PMID: 39487308
PMC: 11530633.
DOI: 10.1038/s41598-024-77259-z.
Impact of porin deficiency on the synergistic potential of colistin in combination with β-lactam/β-lactamase inhibitors against ESBL- and carbapenemase-producing .
Allander L, Vickberg K, Fermer E, Soderhall T, Sandegren L, Lagerback P
Antimicrob Agents Chemother. 2024; 68(11):e0076224.
PMID: 39365067
PMC: 11539213.
DOI: 10.1128/aac.00762-24.
Antibiotics-free compounds for managing carbapenem-resistant bacteria; a narrative review.
Shariati A, Kashi M, Chegini Z, Hosseini S
Front Pharmacol. 2024; 15:1467086.
PMID: 39355778
PMC: 11442292.
DOI: 10.3389/fphar.2024.1467086.
Transmission Dynamics and Novel Treatments of High Risk Carbapenem-Resistant : The Lens of One Health.
Zhu J, Chen T, Ju Y, Dai J, Zhuge X
Pharmaceuticals (Basel). 2024; 17(9).
PMID: 39338368
PMC: 11434721.
DOI: 10.3390/ph17091206.
Klebsiella pneumoniae with carbapenemases: high prevalence of sequence type 307 with bla in South African community hospitals.
Salvador-Oke K, Pitout J, Peirano G, Strydom K, Kingsburgh C, Ehlers M
Eur J Clin Microbiol Infect Dis. 2024; 43(11):2239-2244.
PMID: 39289248
PMC: 11534848.
DOI: 10.1007/s10096-024-04947-z.
In Vitro and In Vivo Assessments of Newly Isolated N4-like Bacteriophage against ST45 K62 Capsular-Type Carbapenem-Resistant : vB_kpnP_KPYAP-1.
Natarajan S, Teh S, Lin L, Lin N
Int J Mol Sci. 2024; 25(17).
PMID: 39273543
PMC: 11395603.
DOI: 10.3390/ijms25179595.
Community context influences the conjugation efficiency of .
Bustamante M, Koopman F, Martens J, Brons J, DelaFuente J, Hackl T
FEMS Microbes. 2024; 5:xtae023.
PMID: 39170752
PMC: 11338288.
DOI: 10.1093/femsmc/xtae023.